Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone

David Kim, Latanya Benjamin, Ashley Wysong, David Hovsepian, Joyce Teng

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Venolymphatic malformations (VLMs) are vascular anomalies consisting of both veins and lymph vessels. A 2-week-old newborn presented with large VLMs on the left forehead, temple, preauricular area, and orbit. Patient was at imminent risk for permanent vision loss due to a localized mass effect. Surgical excision or debulking was contraindicated due to its complexity and proximity to the left eye, and the patient failed to respond to the sildenafil treatment and sclerotherapy. Patient was subsequently started on oral sirolimus 0.8 mg/m2 twice daily in combination with prednisolone 2 mg/kg daily. The patient had an excellent therapeutic outcome for 7 months with complete preservation of vision before treatment was discontinued. However, 2 months after the medical treatments were discontinued, her VLM rebounded. She responded to the combination therapy again after a failed treatment with the mTOR inhibitor alone. This case demonstrates that the sirolimus and prednisolone combination therapy could be beneficial for treatment of complex VLM intractable to other treatments.

Original languageEnglish (US)
Pages (from-to)218-221
Number of pages4
JournalDermatologic Therapy
Volume28
Issue number4
DOIs
StatePublished - Jul 1 2015

Fingerprint

Sirolimus
Prednisolone
Newborn Infant
Therapeutics
Vascular Malformations
Sclerotherapy
Forehead
Lymph
Orbit
Veins

Keywords

  • prednisolone
  • sirolimus
  • vascular malformation
  • venolymphatic malformation

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone. / Kim, David; Benjamin, Latanya; Wysong, Ashley; Hovsepian, David; Teng, Joyce.

In: Dermatologic Therapy, Vol. 28, No. 4, 01.07.2015, p. 218-221.

Research output: Contribution to journalArticle

@article{c5466513c7bd47ebb244cc4afdc91c4f,
title = "Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone",
abstract = "Venolymphatic malformations (VLMs) are vascular anomalies consisting of both veins and lymph vessels. A 2-week-old newborn presented with large VLMs on the left forehead, temple, preauricular area, and orbit. Patient was at imminent risk for permanent vision loss due to a localized mass effect. Surgical excision or debulking was contraindicated due to its complexity and proximity to the left eye, and the patient failed to respond to the sildenafil treatment and sclerotherapy. Patient was subsequently started on oral sirolimus 0.8 mg/m2 twice daily in combination with prednisolone 2 mg/kg daily. The patient had an excellent therapeutic outcome for 7 months with complete preservation of vision before treatment was discontinued. However, 2 months after the medical treatments were discontinued, her VLM rebounded. She responded to the combination therapy again after a failed treatment with the mTOR inhibitor alone. This case demonstrates that the sirolimus and prednisolone combination therapy could be beneficial for treatment of complex VLM intractable to other treatments.",
keywords = "prednisolone, sirolimus, vascular malformation, venolymphatic malformation",
author = "David Kim and Latanya Benjamin and Ashley Wysong and David Hovsepian and Joyce Teng",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/dth.12208",
language = "English (US)",
volume = "28",
pages = "218--221",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone

AU - Kim, David

AU - Benjamin, Latanya

AU - Wysong, Ashley

AU - Hovsepian, David

AU - Teng, Joyce

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Venolymphatic malformations (VLMs) are vascular anomalies consisting of both veins and lymph vessels. A 2-week-old newborn presented with large VLMs on the left forehead, temple, preauricular area, and orbit. Patient was at imminent risk for permanent vision loss due to a localized mass effect. Surgical excision or debulking was contraindicated due to its complexity and proximity to the left eye, and the patient failed to respond to the sildenafil treatment and sclerotherapy. Patient was subsequently started on oral sirolimus 0.8 mg/m2 twice daily in combination with prednisolone 2 mg/kg daily. The patient had an excellent therapeutic outcome for 7 months with complete preservation of vision before treatment was discontinued. However, 2 months after the medical treatments were discontinued, her VLM rebounded. She responded to the combination therapy again after a failed treatment with the mTOR inhibitor alone. This case demonstrates that the sirolimus and prednisolone combination therapy could be beneficial for treatment of complex VLM intractable to other treatments.

AB - Venolymphatic malformations (VLMs) are vascular anomalies consisting of both veins and lymph vessels. A 2-week-old newborn presented with large VLMs on the left forehead, temple, preauricular area, and orbit. Patient was at imminent risk for permanent vision loss due to a localized mass effect. Surgical excision or debulking was contraindicated due to its complexity and proximity to the left eye, and the patient failed to respond to the sildenafil treatment and sclerotherapy. Patient was subsequently started on oral sirolimus 0.8 mg/m2 twice daily in combination with prednisolone 2 mg/kg daily. The patient had an excellent therapeutic outcome for 7 months with complete preservation of vision before treatment was discontinued. However, 2 months after the medical treatments were discontinued, her VLM rebounded. She responded to the combination therapy again after a failed treatment with the mTOR inhibitor alone. This case demonstrates that the sirolimus and prednisolone combination therapy could be beneficial for treatment of complex VLM intractable to other treatments.

KW - prednisolone

KW - sirolimus

KW - vascular malformation

KW - venolymphatic malformation

UR - http://www.scopus.com/inward/record.url?scp=84937728539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937728539&partnerID=8YFLogxK

U2 - 10.1111/dth.12208

DO - 10.1111/dth.12208

M3 - Article

C2 - 25753853

AN - SCOPUS:84937728539

VL - 28

SP - 218

EP - 221

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 4

ER -